Advertisement

The Primary Structure and Posttranslational Modification of Human Hypoxanthine-Guanine Phosphoribosyltransferase

  • James M. Wilson
  • George E. Tarr
  • William N. Kelley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)

Abstract

A complete deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) in man leads to the development of the Lesch-Nyhan syndrome (1) whereas a partial deficiency of the same enzyme leads to a severe form of gout (2). In an attempt to understand the molecular basis of these deficiency states, we have focused our recent studies on the structural and functional properties of HPRT from normal and enzyme-deficient patients.

Keywords

Edman Degradation Complete Amino Acid Sequence Citraconic Anhydride Human HPRT Staphylococcal Protease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.E. Seegmiller, F.M. Rosenbloom, and W.N. Kelley, Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis, Science 155: 1682–1684 (1967).PubMedCrossRefGoogle Scholar
  2. 2.
    W.N. Kelley, F.M. Rosenbloom, J.F. Hendersen, and J.E. Seegmiller, A specific enzyme defect in gout associated with overproduction of uric acid, Proc. Natl. Acad. Sci. USA 57: 1735–1739 (1967).PubMedCrossRefGoogle Scholar
  3. 3.
    W.D.L. Musick, Structural features of the phosphoribosyltranferases and their relationship to the human deficiency disorders of purine and pyrimidine metabolism, C. R. C. Critical Rev. Biochem. 11: 1–34 (1981).CrossRefGoogle Scholar
  4. 4.
    V.I. Zannis, L.J. Gudas, and D.W. Martin, Jr., Characterization of the subunit composition of HGPRTase from human erythrocytes and cultured fibroblasts, Biochem. Genet. 18: 1–19 (1980).PubMedCrossRefGoogle Scholar
  5. 5.
    G.G. Johnson, A.L. Ramage, J.W. Littlefield, and H.H. Kazazian, Jr., Hypoxanthine-guanine phosphoribo-syltransferase in human erythroid cells: post-translational modification, Biochemistry 21: 960–966 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    J.M. Wilsen, B.W. Baugher, P.M. Mattes, P.E. Daddona, and W.N. Kelley, Human hypoxanthine-guanine phosphoribo-syltransferase: demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme, J.Clin. Invest. 69: 706–715 (1982).CrossRefGoogle Scholar
  7. 7.
    J.M. Wilson, B.W. Baugher, L. Landa, and W.N. Kelley, Human hypoxanthine-guanine phosphoribosyltransferase: purification and characterization of mutant forms of the enzyme, J. Biol. Chem. 256: 10306–10312 (1981).PubMedGoogle Scholar
  8. 8.
    J.A. Holden, and W.N. Kelley, Human hypoxanthine-guanine phosphoribosyltransferase: evidence for a tetrameric structure, J. Biol. Chem. 253: 4459–4463 (1978).PubMedGoogle Scholar
  9. 9.
    J.W. Wilson, G.E. Tarr, W.C. Mahoney, and W.N. Kelley, Human hypoxanithine-guanine phosphoribosyltransferase: complete amino acid sequence of the erythrocyte enzyme, J.Biol. Chem. in press (1982).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • James M. Wilson
    • 1
  • George E. Tarr
    • 1
  • William N. Kelley
    • 1
  1. 1.Departments of Internal Medicine and Biological ChemistryUniversity of Michigan Medical CenterAnn ArborUSA

Personalised recommendations